Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulu Baoxinping Oral Liquid for Coronary Heart Disease Ventricular Premature Beats
CTR20132477Phase 3Completed
- Sponsor
- Tonghua Wantong Pharmaceutical
- Start
- Feb 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Fulu Baoxinping Oral Liquid in coronary arteriosclerosis, Premature ventricular complexes (PVC), sponsored by Tonghua Wantong Pharmaceutical. Started Feb 2014; status: completed.
02
Drugs
Fulu Baoxinping Oral Liquid
03
Conditions
coronary arteriosclerosisPremature ventricular complexes (PVC)
Beyond the preview
Go deeper on CTR20132477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132477.